Skip to main content
Premium Trial:

Request an Annual Quote

Deborah Day Barbara, Sanjiv Sam Gambhir

Premium
Strategic Diagnostics said this week Deborah Day Barbara has joined the company as vice president of business development. Her employment became effective Oct. 13.
 
Barbara had been vice president of business development and licensing for Ore Pharmaceuticals. Before that she was senior director of business and technology development for Johns Hopkins University and spent 11 years at Amersham Life Sciences in various sales positions.
 

 
Sanjiv Sam Gambhir has been appointed to the US National Academies Institute of Medicine.
 
Gambhir is the scientific program director at the Canary Foundation where he leads a team of researchers in proteomics, genomics, epigenomics, and other fields. He is also a professor of radiology and bioengineering at Stanford University where he is chief of the nuclear medicine division and director of the Molecular Imaging Program.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.